Ventricular assist devices for heart failure: a focus on patient selection and complications

References

• Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215.
   PubMed Web of Science ®Google Scholar
• Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report – 2012. J Heart Lung Transpl. 2012;31: 1052–1064.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: a 10,000 patients database. J Heart Lung Transplant. 2014;33:555–564.
   PubMed Web of Science ®Google Scholar
• Gilotra NA, Russell SD. Patient selection for mechanical circulatory support. Heart Fail Rev. 2013;18:27–34.
   Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–e327.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur J Heart Fail. 2012;14:803–869.
   PubMed Web of Science ®Google Scholar
• Peura JL, Colvin-Adams M, Francis GS, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection A Scientific Statement from the American Heart Association. Circulation. 2012;126:2648–2667.
   PubMed Web of Science ®Google Scholar
• Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255–263.
   PubMed Web of Science ®Google Scholar
• Flint KM, Matlock DD, Lindenfeld JA, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012;5:286–293.
   PubMed Web of Science ®Google Scholar
• Teuteberg JJ, Ewald GA, Adamson RM, et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol. 2012;60:44–51.
   Web of Science ®Google Scholar
• Yang JA, Kato TS, Shulman BP, et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD Excluding INR (MELD-XI) scoring system. J Heart Lung Transplant. 2012;31:601–610.
   PubMed Web of Science ®Google Scholar
• Cowger J, Sundareswaran K, Rogers JG, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol. 2013;61:313–321.
   PubMed Web of Science ®Google Scholar
• Jorde UP, Kushwaha SS, Tatooles AJ, et al. Results of the destination therapy post-FDA-approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2014;63:1751–1757.
   PubMed Web of Science ®Google Scholar
• Atluri P, Goldstone AB, Fairman AS, et al. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. 2013;96:857–863.
   PubMed Web of Science ®Google Scholar
• Patlolla B, Beygui R, Haddad F. Right ventricular failure following left ventricle assist device implantation. Curr Opin Cardiol. 2013;28: 223–233.
   PubMed Web of Science ®Google Scholar
• Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030–1035.
   PubMed Web of Science ®Google Scholar
• Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–321.
   PubMed Web of Science ®Google Scholar
• Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26:217–229.
   PubMedGoogle Scholar
• Grant AD, Smedira NG, Starling RC, et al. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521–528.
   PubMed Web of Science ®Google Scholar
• Dandel M, Potapov E, Krabatsch T, et al. Load dependency of right ventricular performance is a major factor to be considered in decision making before ventricular assist device implantation. Circulation. 2013;128(11 Suppl 1):S14–S23.
   Web of Science ®Google Scholar
• Raina A, Seetha Rammohan HR, Gertz ZM, et al. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, haemodynamic, and functional parameters. J Card Fail. 2013;19:16–24.
   PubMed Web of Science ®Google Scholar
• Deswarte G, Kirsch M, Lesault PF, et al. Right ventricular reserve and outcome after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2010;29:1196–1198.
   Web of Science ®Google Scholar
• Morgan JA, Paone G, Nemeh HW et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant. 2013;32(4):398–403.
   Google Scholar
• Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–1324.
   PubMed Web of Science ®Google Scholar
• Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883–889.
   PubMed Web of Science ®Google Scholar
• Melenovsky V, Kotrc M, Borlaug BA, et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol. 2013;62:1660–1670.
   PubMed Web of Science ®Google Scholar
• Feldman D, Pamboukian SV, Teuteberg JJ, et al. 2013 ISHLT guidelines for mechanical circulatory support. J Heart Lung Transplant. 2013;32:157–187.
   PubMed Web of Science ®Google Scholar
• Bunte MC, Blackstone EH, Thuita L, et al. Major bleeding during HeartMate II Support. J Am Coll Cardiol. 2013;62:2188–2196.
   Web of Science ®Google Scholar
• Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263–1269.
   PubMed Web of Science ®Google Scholar
• Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33: 679–684.
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol. 2014;63: 880–888.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Pant R, Kumar S, et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg. 2012;93:1534–1540.
   PubMed Web of Science ®Google Scholar
• John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86: 1227–1235.
   PubMed Web of Science ®Google Scholar
• Jennings DL, Jacob M, Chopra A, et al. Safety of anticoagulation reversal in patients supported with continuous-flow left-ventricular assist devices. ASAIO J. Epub 2014 March 20.
   Google Scholar
• Interagency Registry for Mechanically Assisted Circulatory Support, National Heart Lung and Blood Institute. Adverse event definitions. Contract Award HHSN268201100025C. Available from: http://www.uab.edu/medicine/intermacs/manual-of-operations/manual-of-operations-dropdown3/appendix-a-adverse-event-definitions. Accessed December 12, 2013.
   Google Scholar
• Cowger JA, Romano MA, Shah P, et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant. 2014;33:35–43.
   PubMed Web of Science ®Google Scholar
• Ravichandran AK, Parker J, Novak E, et al. Hemolyses in left ventricular assist device: a retrospective analysis of outcomes. J Heart Lung Transplant. 2014;33:44–50.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.
   PubMed Web of Science ®Google Scholar
• Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–59.
   PubMed Web of Science ®Google Scholar
• Uriel N, Morrison KA, Garan AR, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia Ramp Study. J Am Coll Cardiol. 2012;60:1764–1775.
   PubMed Web of Science ®Google Scholar
• Mishkin JD, Enriquez JR, Meyer DM, et al. Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device thrombosis. Circ Heart Fail. 2012;5:e27–e29.
   PubMed Web of Science ®Google Scholar
• Schlendorf K, Patel CB, Gehrig T, et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. J Cardiac Fail. 2014;20:91–97.
   Web of Science ®Google Scholar
• Holman WL. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn? Circulation. 2012;126:1401–1406.
   PubMed Web of Science ®Google Scholar
• Argiriou M, Kolokotron SM, Sakellaridis T, et al. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014;6(S1): S52–S59.
   PubMedGoogle Scholar
• Farrar DJ. Ventricular interactions during mechanical circulatory support. Semin Thorac Cardiovasc Surg. 1994;6:163–168.
   PubMedGoogle Scholar
• Saito S, Sakaguchi T, Miyagawa S, et al. Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure. J Heart Lung Transplant. 2012;31:858–864.
   PubMed Web of Science ®Google Scholar
• John R, Mantz K, Eckman P, et al. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant. 2010; 29:1321–1329.
   PubMed Web of Science ®Google Scholar
• Pak SW, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172–1176.
   PubMed Web of Science ®Google Scholar
• Hatano M, Kinugawa K, Shiga T, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J. 2011;75:1147–1155.
   PubMed Web of Science ®Google Scholar
• Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail. 2010;3:668–674.
   PubMed Web of Science ®Google Scholar
• Martina J, de Jonge N, Sukkel E, Lahpor J. Left ventricular assist device-related systolic aortic regurgitation. Circulation. 2011;124:487–488.
   PubMedGoogle Scholar
• Cohn WE, Demirozu ZT, Frazier OH. Surgical closure of left ventricular outflow tract after left ventricular assist device implantation in patients with aortic valve pathology. J Heart Lung Transplant. 2011;30: 59–63.
   Web of Science ®Google Scholar
• Farrar DJ, Bourque K, Reichenbach SH, Muller P, Peri L. . Innovation update. In: Kyo S, editor. Ventricular Assist Devices in Advanced-Stage Heart Failure. Japan, Tokyo: Springer; 2014. Available from: http://issuu.com/chiasmatta/docs/4431544658. Accessed August 5, 2014.
   Google Scholar
• Boyle A. Arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol. 2012;27:13–18.
   PubMed Web of Science ®Google Scholar
• Maisel W, Stevenson L. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003; 91 Suppl:2D–8D.
   Web of Science ®Google Scholar
• Oswald H, Schultz-Wildelau C, Gardiwal A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593–599.
   PubMed Web of Science ®Google Scholar
• Pedrotty DM, Rame JE, Marguilies KB. Management of ventricular arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol. 2013;28:360–368.
   Web of Science ®Google Scholar
• Gregory SD, Timms D, Gaddum NR, et al. In vitro evaluation of a compliant inflow cannula reservoir to reduce suction events with extracorporeal rotary ventricular assist device support. Artif Organs. 2011;35: 765–772.
   PubMed Web of Science ®Google Scholar
• Klotz S, Foronjy RF, Dickstein ML, et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen crosslinking and myocardial stiffness. Circulation. 2005;112: 364–374.
   PubMed Web of Science ®Google Scholar
• Harding JD, Piacentino V 3rd, Gaughan JP, et al. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 2001;104:1241–1247.
   PubMed Web of Science ®Google Scholar
• Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29:515–527.
   PubMed Web of Science ®Google Scholar
• Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30:375–384.
   PubMed Web of Science ®Google Scholar
• Pratt AK, Shah NS, Boyce SW. Left ventricular assist device management in the ICU. Crit Care Med. 2014;42:158–168.
   Web of Science ®Google Scholar
• Walker PC, DePestel DD, Miles NA, Malani PN. Surgical infection prophylaxis for left ventricular assist device implantation. J Card Surg. 2011;26:440–443.
   PubMed Web of Science ®Google Scholar
• Adzic A, Patel SR, Maybaum S. Impact of adverse events on ventricular assist device outcomes. Curr Heart Fail Rep. 2013;10:89–100.
   Google Scholar